Drug Type T-lymphocyte cell therapy |
Synonyms- |
Target |
Action modulators |
Mechanism IL-15Rα modulators(Interleukin-15 receptor subunit alpha modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Osteosarcoma | Preclinical | United Kingdom | 29 May 2024 |





